Federal-Mogul Izmit Piston Ve Pim Üretim Tesisleri A.S. (IST:FMIZP)

CTI BioPharma Income Statement

Financials in millions TRY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	609.02	675.7	388.99	600.99	187.87	87.19
Revenue Growth (YoY)	24.89%	73.71%	-35.28%	219.90%	115.46%	-24.07%
Cost of Revenue	507.79	549.89	359.1	501.46	134.95	60.51
Gross Profit	101.22	125.8	29.89	99.53	52.92	26.68
Selling, General & Admin	35.93	34.7	14.63	27.23	8.53	4.46
Other Operating Expenses	-31.78	-32.84	-53.82	-28.43	-5.98	-2.11
Operating Expenses	4.15	1.86	-39.19	-1.19	2.55	2.35
Operating Income	97.08	123.94	69.07	100.73	50.37	24.33
Interest Expense	-1.8	-0.13	-0.05	-1.31	-0.3	-0.2
Interest & Investment Income	29.06	27.38	17.86	15.39	4.81	5.17
Currency Exchange Gain (Loss)	-14.65	-18.74	-52.16	-24.39	24.51	9.27
EBT Excluding Unusual Items	109.69	132.46	34.73	90.41	79.39	38.56
Gain (Loss) on Sale of Investments	-	-	-	-	-	-0
Pretax Income	109.69	132.46	34.73	90.41	79.39	38.56
Income Tax Expense	22.93	23.46	11	20.41	12.7	8.03
Net Income	86.76	109	23.73	70	66.69	30.53
Net Income to Common	86.76	109	23.73	70	66.69	30.53
Net Income Growth	72.61%	359.38%	-66.10%	4.97%	118.43%	-3.20%
Shares Outstanding (Basic)	14	14	14	14	14	14
Shares Outstanding (Diluted)	14	14	14	14	14	14
EPS (Basic)	6.08	7.63	1.66	4.90	4.67	2.14
EPS (Diluted)	6.08	7.63	1.66	4.90	4.67	2.14
EPS Growth	72.61%	359.38%	-66.10%	4.97%	118.43%	-3.20%
Free Cash Flow	104.97	123.79	11.29	51.11	34.64	28.76
Free Cash Flow Per Share	7.35	8.67	0.79	3.58	2.43	2.01
Dividend Per Share	0.705	0.705	-	1.460	4.465	-
Dividend Growth	-	-	-	-67.29%	-	-
Gross Margin	16.62%	18.62%	7.68%	16.56%	28.17%	30.60%
Operating Margin	15.94%	18.34%	17.76%	16.76%	26.81%	27.90%
Profit Margin	14.25%	16.13%	6.10%	11.65%	35.49%	35.01%
Free Cash Flow Margin	17.24%	18.32%	2.90%	8.50%	18.44%	32.98%
EBITDA	121.87	150.25	77.55	113.21	51.62	25.88
EBITDA Margin	20.01%	22.24%	19.94%	18.84%	27.47%	29.68%
D&A For EBITDA	24.79	26.31	8.47	12.48	1.25	1.55
EBIT	97.08	123.94	69.07	100.73	50.37	24.33
EBIT Margin	15.94%	18.34%	17.76%	16.76%	26.81%	27.90%
Effective Tax Rate	20.91%	17.71%	31.67%	22.57%	16.00%	20.83%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.